Resources
About Us
Mental-Care & Nootropic Ingredients Market by Ingredient Type, Function/Benefit, Formulation, Application, Distribution Channel, and Geography - Global Forecast to 2035
Report ID: MRFB - 1041624 Pages: 225 Nov-2025 Formats*: PDF Category: Food and Beverages Delivery: 24 to 72 Hours Download Free Sample ReportWhat is the Mental-Care & Nootropic Ingredients Market Size?
The global mental-care & nootropic ingredients market was valued at USD 4.75 billion in 2024. This market is expected to reach USD 12.73 billion by 2035 from USD 5.22 billion in 2025, at a CAGR of 9.5% from 2025 to 2035.
The rise in mental health disorders like stress, anxiety, and depression is making people more aware of cognitive health and brain wellness. There is a higher demand for natural and plant-based mental wellness solutions. An aging population is increasingly worried about cognitive decline, and more people accept preventive mental healthcare. Improvements in ingredient effectiveness and clinical validation are also helping the use of mental-care and nootropic ingredients in dietary supplements, functional foods and drinks, pharmaceuticals, and personal care products worldwide.
Market Highlights: Mental-Care & Nootropic Ingredients

Click here to: Get Free Sample Pages of this Report
The mental care and nootropic ingredients include those sourced from botanical extracts, synthesized compounds, amino acids, vitamins, minerals, probiotics, and omega-3 fatty acids. Mental-care ingredients target stress, anxiety, mood disorders, and emotional wellness, whereas nootropics address cognitive improvement: memory, focus, learning capabilities, clarity of mind, and neuroprotection.
It contains traditional adaptogens such as ashwagandha, rhodiola, and ginseng to help the body deal with stress responses; amino acids such as L-theanine and GABA for relaxation and mental calmness; B-vitamins and magnesium to support neurological function; omega-3 fatty acids like DHA and EPA important for brain structure and function; and emerging probiotics to influence the gut-brain axis. These ingredients are formulated into a range of delivery formats including capsules, tablets, powders, beverages, gummies, and functional foods in order to cater for diverse consumer preferences and usage occasions.
Mental wellness is increasingly recognized as integral to overall health, and consumers are gradually shifting from reactive treatment to proactive prevention and daily cognitive optimization. The COVID-19 pandemic significantly accelerated awareness of mental health issues and self-care practices, normalizing conversations around anxiety, stress management, and emotional resilience. Growing scientific research that validates the efficacy of natural nootropics and adaptogens, regulatory acceptance of mental wellness claims in various markets, the rise of personalized nutrition approaches targeting individual cognitive needs, and strong investment by supplement manufacturers and functional beverage brands in mental wellness categories propel the growth of the overall mental care & nootropic ingredients market.
What are the Key Trends in the Mental-Care & Nootropic Ingredients Market?
Gut-brain axis and psychobiotic innovation: One of the transformative trends in the growth of the mental-care and nootropic ingredients market has been the increased focus on the gut-brain axis and developing psychobiotics, a probiotic selectively chosen for mental health functionality. Emerging evidence places the gut microbiome as influencing mood, cognition, stress response, and neurological health through diverse mechanisms that include neurotransmitter production, immune system modulation, and vagal nerve signaling. Certain strains like Lactobacillus helveticus, Bifidobacterium longum, and Lactobacillus rhamnosus have shown promising clinical evidence for reducing anxiety, improving mood, and enhancing resilience to stress.
The trend is pushing ingredient innovation beyond traditional botanical adaptogens and amino acids to microbiome-targeting solutions. Probiotic manufacturers are developing multi-strain probiotic formulations optimized for mental well-being, while combining psychobiotics with prebiotics and postbiotics to ramp up gut health and mental health outcomes. Scientific validation of the gut-brain connection-what happens in the gut does make its way to the brain-is rewriting product development strategies for both cognitive and mood support, as brands increasingly incorporate digestive health ingredients into their formulations. This approach finds particular appeal among health-conscious consumers looking for holistic, root-cause solutions rather than symptom management.
Functional beverage expansion and nootropic coffee alternatives: Another significant trend driving market growth is the rapid expansion of functional beverages that feature mental care and nootropic ingredients as an alternative or enhancement to traditional caffeinated beverages. Consumers increasingly seek out beverages that offer mental benefits beyond energy alone, including sustained focus without jitters, stress relief, mood enhancement, and improved cognitive performance. This has spawned new beverages in categories including adaptogenic coffee blends that combine traditional coffee with ashwagandha or lion's mane mushroom, nootropic energy drinks featuring L-theanine, GABA, and B-vitamins for calm alertness, and mushroom-based coffee alternatives with lion's mane and cordyceps.
Major beverage companies are entering the functional mental wellness space through product innovation, acquisitions of specialized brands, and partnerships with ingredient suppliers. The trend is especially strong among younger consumers who favor experiential products and are willing to pay premium prices for beverages supporting their mental performance and emotional wellbeing. This trend is creating substantial opportunities for ingredient suppliers to develop beverage-optimized formulations that feature good taste profiles, stability in liquid formats, and appropriate dosing for frequent consumption patterns.
|
Report Coverage |
Details |
|
Market Size by 2035 |
USD 12.73 Billion |
|
Market Size in 2025 |
USD 5.22 Billion |
|
Market Size in 2024 |
USD 4.75 Billion |
|
Market Growth Rate from 2025 to 2035 |
CAGR of 9.5% |
|
Dominating Region |
North America |
|
Fastest Growing Region |
Asia Pacific |
|
Base Year |
2024 |
|
Forecast Period |
2025 to 2035 |
|
Segments Covered |
Ingredient Type, Function/Benefit, Formulation, Application, Distribution Channel, and Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Mrket Dynamics
Drivers
Growing Prevalence of Mental Health Disorders and Stress-Related Conditions
A rapid increase in mental health disorders and stress-related conditions is one of the main factors driving the market for mental-care and nootropic ingredients. Based on data from the World Health Organization, it is estimated that together, depression and anxiety cost the global economy approximately USD 1 trillion in lost productivity annually. Today, an estimated 280 million people live with depression, and roughly 301 million with anxiety disorders. These numbers have grown sharply since the COVID-19 pandemic, which intensified mental health struggles due to social isolation, financial uncertainty, and disrupted daily routines.
Modern living also plays a major role in heightening mental strain: long work hours, constant digital engagement leading to attention fatigue, irregular sleep, inadequate diet, and social disconnection all combine in widespread burnout and emotional exhaustion. Meanwhile, an aging population worldwide is increasingly concerned about cognitive decline, dementia, and the desire to keep their mental faculties sharp. This has increased interest in neuroprotective and cognitive-enhancing ingredients. At the other end of the demographic spectrum, young people, particularly millennials and Gen Z are showing an increasing sensitivity to mental wellness. They increasingly turn to preventive and performance-supportive solutions to help them master everyday stress, improve focus, and maintain emotional balance for success in both studies and work.
Opportunity
Expanding Clinical Validation and Regulatory Acceptance of Mental Wellness Claims
Together, a growing body of clinical research validating mental-care and nootropic ingredients and evolving regulations that permit mental wellness and cognitive function claims are opening significant market opportunities. Historically, strict regulations had constrained the claims manufacturers could make about mental and cognitive benefits. Today, stronger scientific evidence such as ashwagandha’s stress-reducing effects, L-theanine’s calming properties, lion’s mane mushroom’s neuroprotective benefits, and omega-3 fatty acids’ role in brain health supports regulatory acceptance.
Regulatory bodies are bringing clarity to pathways for mental wellness claims: the European Food Safety Authority enables certain claims for DHA, B-vitamins, and magnesium; the U.S. FDA's structure/function framework allows science-based communication of benefits for mental wellness. Likewise, Japan's Foods with Function Claims and China's health food registration processes are driving new opportunities in Asia.
This move enables brands to communicate specific mental health benefits, rather than general wellness benefits. Clinical validation of traditional botanicals increases consumer confidence and connects traditional knowledge with evidence-based nutrition, particularly for China and India. The investment in clinical trials, proprietary formulation, and regulatory approval provides companies with a competitive advantage through premium positioning. Biomarkers for mental well-being, personalized formulation, and integrated digital solutions that link ingredient intake to cognitive performance are some areas where future growth will be focused.
Ingredient Type Insights
Why Do Botanical Extracts/Adaptogens Dominate the Market?
The botanical extracts/adaptogens segment is expected to hold the largest share of the overall mental-care & nootropic ingredients market in 2025, driven primarily by the strong consumer preference for natural, plant-based solutions to mental wellness challenges, the extensive traditional use histories of adaptogenic herbs in both Ayurvedic and Traditional Chinese Medicine systems, and the growing clinical validation of their stress-modulating and cognitive-supporting effects.
However, the probiotics/microbiome-based segment is expected to witness the fastest growth during the forecast period, driven by emerging research on the gut-brain axis, increasing consumer awareness of microbiome influence on mental health, and development of clinically validated psychobiotic strains that specifically target mental wellness outcomes through mechanisms different from those of traditional cognitive supplements.
Function/Benefit Insights
How Does Stress/Anxiety Relief Lead the Market?
The stress/anxiety relief segment commands the largest share of the overall mental-care & nootropic ingredients market in 2025. This is because stress-related conditions are widely prevalent among people of all age groups and demographics, the management of stress in modern life is of universal relevance, and improving emotional well-being and mental calmness is being increasingly prioritized by consumers as basic to health and productivity.
The ingredients for stress and anxiety relief include adaptogens that modulate cortisol responses and enhance stress resilience, such as ashwagandha and rhodiola; amino acids that promote relaxation without sedation, like L-theanine and GABA; magnesium, which plays an important role in supporting nervous system function and regulation of stress responses; and botanical extracts like passionflower and lemon balm, known for their calming properties.
Among the application segments, the cognitive performance/memory/focus/learning segment is expected to grow at the fastest CAGR during the forecast period. This growth is driven by increased competition in educational and professional settings that require sustained mental performance; increased interest on the part of students and professionals looking to enhance their cognitive capabilities for competitive advantage; increased concern about age-associated cognitive decline and the desire to remain mentally sharp; and emergence of work-from-home arrangements and digital learning environments that require extended periods of time spent focusing and maintaining mental stamina in the absence of traditional workplace or classroom structures.
Application Insights
How Do Dietary Supplements Drive Market Demand?
Dietary supplements, by application, represent the leading market share in 2025 owing to established consumer behavior related to the use of dietary supplements for targeted health benefits, significant investment in product innovation and marketing in the supplement category, regulatory frameworks in most markets that allow cognitive and mental wellness claims in dietary supplements, and wide availability through multiple distribution channels such as specialty health stores, pharmacies, and e-commerce.
The functional foods & beverages segment is projected to grow at the fastest CAGR during the forecast period. This growth is driven by consumer preference for delivering health benefits through regular food and beverage consumption rather than medicinal-feeling pills, the success of functional beverage brands positioning cognitive and mood benefits as core product attributes, the ability to reach consumers outside traditional supplement buyer demographics through food and beverage channels, innovations in food technology enabling the incorporation of effective doses of mental wellness ingredients without compromising taste and texture, and lifestyle-oriented positioning of functional foods and beverages that puts mental wellness in sync with broader wellness trends including fitness, mindfulness, and self-care.
Distribution Channel Insights
Why Does B2B Lead the Market?
B2B segment holds the largest share of the overall market, as the mental-care & nootropic ingredients market is largely characterized by ingredient suppliers selling to manufacturers of finished consumer products. The segment includes transactions between raw material producers, ingredient processors and standardizers, and finished product manufacturers, including supplement brands, functional food companies, beverage manufacturers, and pharmaceutical companies.
The extensive reformulation activity is driven by the B2B segment as brands across categories integrate ingredients for mental wellness into existing lines and launch products in cognitive health and stress management categories. Long-term supply contracts with ingredient suppliers and large manufacturers give stable revenue channels and allow for capacity planning of cultivation, extraction, and processing operations. The segment includes both commodity ingredients that are mainly sold on price and specification and proprietary branded ingredients commanding premium pricing through clinical validation, patented extraction processes, or superior bioavailability profiles.
U.S. Mental-Care & Nootropic Ingredients Market Size and Growth 2025 to 2035
The U.S. mental-care & nootropic ingredients market is projected to grow at a CAGR of 8.6% from 2025 to 2035.
How is North America Maintaining Dominance in the Mental-Care & Nootropic Ingredients Market?
North America dominates the global market for mental-care & nootropic ingredients with a share of around 35-40% in 2025, driven by high consumer awareness of mental wellness and cognitive health, high market penetration of dietary supplements and functional foods, significant marketing investment by large supplement and beverage brands in mental wellness categories, a relatively permissive regulatory environment regarding structure/function claims related to cognitive and psychological function, high healthcare costs increasing consumer interest in preventive and complementary approaches, and high levels of research and development activity in neuroscience and nutritional psychiatry.
The U.S. leads the North American market with the largest dietary supplement industry globally, valued at over $50 billion annually. Mental wellness and cognitive health are two of the fast-growing subcategories. Compared to the rest of the world, a significantly higher number of US consumers is willing to pay for high-quality products offering improved mental performance, stress mitigation, and longer-term cognitive health.
This is further supported by a very strong ecosystem of ingredient suppliers, contract manufacturers, supplement brands, and functional food and beverage companies, as well as retail channels specializing in health and wellness products. E-commerce penetration is exceptionally high, with Amazon, iHerb, and direct-to-consumer brands making mental wellness products highly accessible. The COVID-19 pandemic significantly accelerated mental wellness awareness in North America, with reported increases in anxiety, stress, and depression symptoms driving demand for natural support solutions.
Which Factors Support the Growth of the Asia Pacific Mental-Care & Nootropic Ingredients Market?
Asia Pacific is expected to grow at the fastest CAGR between 2025 and 2035. Such exceptional growth is supported by several factors, such as fast-increasing mental health awareness and destigmatization of mental health issues in traditionally conservative societies, rising stress levels associated with rapid urbanization, intense educational and workplace competition, and changing family structures reducing traditional support systems. Additionally, factors such as a growing middle class having disposable income to invest in wellness products and preventive healthcare, strong cultural traditions of using botanical medicines for mental and cognitive support in Traditional Chinese Medicine, Ayurveda, and other traditional systems, creating acceptance for plant-based mental wellness ingredients; increasing prevalence of lifestyle-related mental health conditions, including anxiety, depression, and stress disorders across the region; and expanding regulatory frameworks within countries such as China, Japan, and South Korea that enable mental wellness and cognitive function claims further drive the growth of this market.
The large and growing population of the region, especially in China and India, provides enormous market potential even at relatively low per-capita consumption compared to developed Western markets. Economic development across Southeast Asia, including Indonesia, Vietnam, Thailand, and Philippines, is extending the addressable market for mental wellness products beyond traditional high-income countries such as Japan, South Korea, Singapore, and Australia. Regulatory reforms and the health food registration system continue to open up the market for mental wellness ingredients and products in China, although regulatory complexity remains a challenge.
The younger demographic profile in many Asia Pacific countries therefore creates a large consumer base interested in cognitive enhancement for competitive advantage in education and at work. At both ends of the age spectrum, demand is growing driven by growing mental health challenges among students facing intense academic pressure, young professionals navigating demanding workplaces, and elderly populations concerned about cognitive aging.
The region also serves as a major manufacturing base, both for ingredient production and finished product manufacturing, with contract manufacturers in China, India, and Southeast Asia supplying global markets. The rapid growth of e-commerce and digital payment systems throughout Asia Pacific accelerates market accessibility, especially for innovative functional beverage brands and direct-to-consumer supplement companies using social commerce and influencer marketing to reach consumers.
Segments Covered in the Report
By Ingredient Type
By Function
By Formulation
By Application / End-Use Industry
By Distribution Channel
By Region
The mental-care & nootropic ingredients market is expected to grow from USD 5.22 billion in 2025 to USD 12.73 billion by 2035.
The mental-care & nootropic ingredients market is expected to grow at a CAGR of 9.5% from 2025 to 2035.
The major players in the mental-care & nootropic ingredients market include Sabinsa Corporation, Arjuna Natural Pvt. Ltd., Ixoreal Biomed Inc., Natreon Inc., Verdure Sciences (Lonza), Kyowa Hakko Bio Co. Ltd., Chr. Hansen Holding A/S (Novonesis), DSM-Firmenich, Nexira, Nammex (North American Medicinal Mushroom Extracts), Pharmachem Laboratories, Organic Herb Inc., Daesang Corporation, Glanbia Nutritionals, and Roquette Frères among others.
The key factors driving the mental-care & nootropic ingredients market include growing prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of preventive mental healthcare and cognitive wellness, rising demand for natural and plant-based mental wellness solutions, expanding scientific validation and clinical evidence for nootropic and adaptogenic ingredients, growing acceptance of self-care and proactive mental health management, technological advancements in ingredient extraction and bioavailability enhancement, and expanding elderly population concerned about cognitive decline and brain health.
North America region will lead the global mental-care & nootropic ingredients market during the forecast period 2025 to 2035.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Bottom-Up Approach
2.3.3. Top-Down Approach
2.3.4. Growth Forecast
2.4. Assumptions for the Study
3. Executive Summary
3.1. Overview
3.2. Market Analysis, By Ingredient Type
3.3. Market Analysis, By Function/Benefit
3.4. Market Analysis, By Formulation
3.5. Market Analysis, By Application
3.6. Market Analysis, By Distribution Channel
3.7. Market Analysis, By Geography
3.8. Competitive Analysis
4. Market Insights
4.1. Introduction
4.2. Global Mental-Care & Nootropic Ingredients Market: Impact Analysis of Market Drivers (2025-2035)
4.2.1. Growing Prevalence of Mental Health Disorders and Stress-Related Conditions
4.2.2. Increasing Consumer Awareness of Cognitive Health and Preventive Mental Wellness
4.2.3. Rising Demand for Natural and Plant-Based Solutions
4.3. Global Mental-Care & Nootropic Ingredients Market: Impact Analysis of Market Restraints (2025-2035)
4.3.1. Regulatory Variability and Claim Restrictions Across Markets
4.3.2. Limited Clinical Evidence for Some Emerging Ingredients
4.4. Global Mental-Care & Nootropic Ingredients Market: Impact Analysis of Market Opportunities (2025-2035)
4.4.1. Expanding Clinical Validation and Regulatory Acceptance of Mental Wellness Claims
4.4.2. Growing Functional Beverage and Food Integration
4.5. Global Mental-Care & Nootropic Ingredients Market: Impact Analysis of Market Challenges (2025-2035)
4.5.1. Quality Control and Standardization Issues
4.5.2. Supply Chain and Raw Material Sourcing Challenges
4.6. Global Mental-Care & Nootropic Ingredients Market: Impact Analysis of Market Trends (2025-2035)
4.6.1. Gut-Brain Axis and Psychobiotic Innovation
4.6.2. Functional Beverage Expansion and Nootropic Coffee Alternatives
4.7. Porter's Five Forces Analysis
4.7.1. Threat of New Entrants
4.7.2. Bargaining Power of Suppliers
4.7.3. Bargaining Power of Buyers
4.7.4. Threat of Substitute Products
4.7.5. Competitive Rivalry
5. The Impact of Ingredient Innovation and Technology on the Global Mental-Care & Nootropic Ingredients Market
5.1. Introduction to Ingredient Innovation and Bioavailability Enhancement
5.2. Advanced Extraction and Standardization Technologies
5.3. Bioavailability Enhancement and Delivery System Innovation
5.4. Clinical Validation and Evidence-Based Ingredient Development
5.5. Sustainable Sourcing and Vertical Integration Strategies
5.6. Proprietary Ingredient Development and Branded Ingredients
5.7. Quality Control and Analytical Testing Advancements
5.8. Impact on Market Growth and Competitive Differentiation
6. Competitive Landscape
6.1. Introduction
6.2. Key Growth Strategies
6.2.1. Market Differentiators
6.2.2. Synergy Analysis: Major Deals & Strategic Alliances
6.3. Competitive Dashboard
6.3.1. Industry Leaders
6.3.2. Market Differentiators
6.3.3. Vanguards
6.3.4. Emerging Companies
6.4. Vendor Market Positioning
6.5. Market Share/Ranking by Key Players
7. Global Mental-Care & Nootropic Ingredients Market, By Ingredient Type
7.1. Introduction
7.2. Botanical Extracts / Adaptogens
7.2.1. Ashwagandha
7.2.2. Rhodiola
7.2.3. Ginseng
7.2.4. Lion's Mane & Other Mushroom Extracts
7.2.5. Bacopa Monnieri
7.2.6. Holy Basil (Tulsi)
7.2.7. Ginkgo Biloba
7.2.8. Others (Passionflower, Lemon Balm, Valerian Root)
7.3. Amino Acids
7.3.1. L-Theanine
7.3.2. GABA (Gamma-Aminobutyric Acid)
7.3.3. L-Tyrosine
7.3.4. 5-HTP (5-Hydroxytryptophan)
7.3.5. Others
7.4. Vitamins & Minerals
7.4.1. B-Vitamins
7.4.2. Magnesium
7.4.3. Zinc
7.4.4. Vitamin D
7.4.5. Others
7.5. Omega-3 / Lipids
7.5.1. DHA (Docosahexaenoic Acid)
7.5.1.1. Algal DHA
7.5.1.2. Fish-Derived DHA
7.5.2. EPA (Eicosapentaenoic Acid)
7.5.3. Phospholipids (Phosphatidylserine, Phosphatidylcholine)
7.6. Probiotics / Microbiome-Based
7.6.1. Lactobacillus Strains
7.6.2. Bifidobacterium Strains
7.6.3. Multi-Strain Psychobiotic Formulations
7.6.4. Prebiotics and Postbiotics
7.7. Synthetic Nootropics
7.7.1. Citicoline (CDP-Choline)
7.7.2. Alpha-GPC (Alpha-Glycerylphosphorylcholine)
7.7.3. Others
7.8. Others
8. Global Mental-Care & Nootropic Ingredients Market, By Function
8.1. Introduction
8.2. Stress / Anxiety Relief
8.3. Mood Enhancement / Emotional Well-Being
8.4. Cognitive Performance (Memory, Focus, Learning)
8.5. Neuroprotection / Brain Health
8.6. Sleep / Recovery
8.7. Energy & Mental Fatigue
9. Global Mental-Care & Nootropic Ingredients Market, By Formulation
9.1. Introduction
9.2. Capsules / Tablets
9.3. Powder / Drink Mixes
9.4. Liquids / Drops / Tinctures
9.5. Beverages / RTD (Ready-to-Drink)
9.6. Gummies / Chewables
9.7. Functional Foods
9.8. Others
10. Global Mental-Care & Nootropic Ingredients Market, By Application / End-Use Industry
10.1. Introduction
10.2. Dietary Supplements
10.3. Functional Foods & Beverages
10.4. Personal Care / Nutraceutical Cosmetics
10.5. Pharmaceuticals / Clinical Mental Health Use
10.6. Sports Nutrition
10.7. Others
11. Global Mental-Care & Nootropic Ingredients Market, By Distribution Channel
11.1. Introduction
11.2. Direct Sales to Manufacturers
11.3. Distributors and Ingredient Brokers
11.4. Online B2B Platforms
11.5. Others
12. Global Mental-Care & Nootropic Ingredients Market, By Geography
12.1. Introduction
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Switzerland
12.3.7. Rest of Europe
12.4. Asia-Pacific
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. South Korea
12.4.5. Australia
12.4.6. Southeast Asia
12.4.6.1. Indonesia
12.4.6.2. Thailand
12.4.6.3. Singapore
12.4.6.4. Vietnam
12.4.6.5. Philippines
12.4.7. Rest of Asia-Pacific
12.5. Latin America
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
12.6. Middle East & Africa
12.6.1. Saudi Arabia
12.6.2. UAE
12.6.3. South Africa
12.6.4. Rest of Middle East & Africa
13. Company Profiles
13.1. Sabinsa Corporation
13.2. Arjuna Natural Pvt. Ltd.
13.3. Ixoreal Biomed Inc. (KSM-66 Ashwagandha)
13.4. Natreon Inc.
13.5. Verdure Sciences (Lonza - Capsules & Health Ingredients)
13.6. Kyowa Hakko Bio Co. Ltd.
13.7. Chr. Hansen Holding A/S (Novonesis)
13.8. DSM-Firmenich (Royal DSM)
13.9. Nexira
13.10. Nammex
13.11. Pharmachem Laboratories (Nutraceutical International Corporation)
13.12. Organic Herb Inc.
13.13. Daesang Corporation
13.14. Glanbia Nutritionals (Glanbia plc)
13.15. Roquette Frères
14. Appendix
14.1. Questionnaire
14.2. Available Customization
Published Date: Feb-2025
Published Date: Jan-2025
Published Date: Jan-2025
Published Date: Oct-2024
Published Date: Aug-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates